Concepedia

Robert M. Conry

RM

Statistics

Publications

69

Citations

6.2K

H-Index

37

Active since

1994

Affiliations

University of Alabama at Birmingham(Current)

The University of Texas MD Anderson Cancer Center

Moffitt Cancer Center

Kirklin Clinic

Melanoma Institute Australia

Robert M. Conry is an author at University of Alabama at Birmingham specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

1994–2022

69

Publications

69

gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma

Douglas J. Schwartzentruber, David H. Lawson, Jon Richards et al. · New England Journal of Medicine · 2011 · 878 citations

Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

Agop Y. Bedikian, Michael Millward, Hubert Pehamberger et al. · Journal of Clinical Oncology · 2006 · 596 citations

Sorafenib for Advanced and Refractory Desmoid Tumors

Mrinal M. Gounder, Michelle R. Mahoney, Brian A. Van Tine et al. · New England Journal of Medicine · 2018 · 431 citations · Full text

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced <i>BRAF</i>-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134

Michael B. Atkins, Sandra J. Lee, Bartosz Chmielowski et al. · Journal of Clinical Oncology · 2022 · 402 citations · Full text

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Michele Maio, Karl D. Lewis, Lev Demidov et al. · The Lancet Oncology · 2018 · 210 citations · Full text

, , +10

1–5 of 69